Indemnify® represents a new cornerstone in integrated nematode management programs for turfgrass. Indemnify is a next generation, easy-to-use nematicide that controls key plant parasitic nematodes and improves root growth and turfgrass health resulting in better playability with improved wear tolerance.
Indemnify is a unique liquid formulation with soil penetrating surfactants specifically formulated for nematode control in turfgrass.
James Royal, Turf Market Manager for Bayer says “High populations of plant parasitic nematodes can present significant challenges for maintaining turfgrass consistency and playability. We look forward to working with our agents and turf managers over the coming weeks and months to introduce this new technology and ensure that our customers who face issues with plant parasitic nematodes enjoy the benefits which come from using Indemnify.”
Indemnify is available from Bayer’s appointed agent network from the 1st July and comes in a convenient 500mL bottle.
Signature Xtra Stressgard® is a new and innovative fungicide that delivers excellent disease control and enhanced plant health effects resulting in improved playability on turf surfaces.
Signature Xtra Stressgard is a true systemic fungicide that controls tough turf diseases – pythium and anthracnose, as well as enhancing turf health and minimising turf stress from abiotic and biotic sources. A new and improved formulation of fosetyl-aluminium, optimised with new proprietary components to provide excellent preventative control of turf disease and turf health improvement even under the most severe environmental conditions.
The label for Signature Xtra Stressgard contains a choice of rates and application intervals to offer turf managers outstanding flexibility to tailor programs for the specific conditions at their facility and to fit in with preferred application practices.
Jyri Kaapro, Senior Market Development Specialist – Turf/VM for Bayer says “Signature Stressgard has been a known and trusted product, adopted as the backbone of summer disease management programs for more than 20 years here in Australia. Signature Xtra Stressgard is one of Bayer’s most extensively researched innovations in recent times. The large number of local and overseas trials have demonstrated performance that delivers a new level of benefit to turf managers all over Australia who manage surfaces that encounter biotic (eg. disease) and abiotic (eg. heat, traffic, shade etc.) stresses. I look forward to connecting with our turf agents and turf managers all over Australia in coming months to share and discuss how to get the best results from Signature Xtra Stressgard this coming summer season.”
Signature Xtra Stressgard will be sold in a convenient and easy to use, 2.75 kg HDPE bottle and will be available in the latter part of 2019. Until that time, Signature Stressgard 2.5kg will continue to be available.
For further information:
(m) 0408 903 252
About Bayer in Australia
Bayer is a global enterprise with core competencies in the Life Science fields of healthcare and agriculture. Its products and services are designed to benefit people and improve their quality of life. It has operated in Australia since 1925 and has a long term commitment to the health of Australians. Locally, Bayer currently employs almost 900 people across the country and is dedicated to servicing the needs of rural Australia and the local community. Bayer is deeply committed to research and development and has a strong tradition of innovation. The company’s focus on people, partnerships and innovation underpins all aspects of its operations, consistent with its mission, “Bayer: Science For A Better Life.” crop.bayer.com.au
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.